Cargando…
Oral kallidinogenase improved visual acuity and maintained chorioretinal blood flow levels after treatment for diabetic macular edema
PURPOSE: This study was designed to investigate the therapeutic effects of oral kallidinogenase medication as an adjuvant therapy in treating patients with diabetic macular edema (DME). STUDY DESIGN: This was a prospective, open-labeled, randomized study. METHODS: All patients were given posterior s...
Autores principales: | Tsuiki, Eiko, Suzuma, Kiyoshi, Matsumoto, Makiko, Mohamed, Yasser Helmy, Kitaoka, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158001/ https://www.ncbi.nlm.nih.gov/pubmed/30275681 http://dx.doi.org/10.2147/OPTH.S168420 |
Ejemplares similares
-
RETINAL BLOOD FLOW AFTER INTRAVITREAL BEVACIZUMAB IS A PREDICTIVE FACTOR FOR OUTCOMES OF MACULAR EDEMA ASSOCIATED WITH CENTRAL RETINAL VEIN OCCLUSION
por: Matsumoto, Makiko, et al.
Publicado: (2018) -
Retinal Vascular Resistance Significantly Correlates With Visual Acuity After 1 Year of Anti-VEGF Therapy in Central Retinal Vein Occlusion
por: Matsumoto, Makiko, et al.
Publicado: (2021) -
Visual outcomes and prognostic factors in open-globe injuries
por: Fujikawa, Azusa, et al.
Publicado: (2018) -
Retro-mode imaging of fibrovascular membrane in proliferative diabetic retinopathy after intravitreal bevacizumab injection
por: Suzuma, Kiyoshi, et al.
Publicado: (2011) -
Retinal Microvascular Resistance Estimated from Waveform Analysis Is Significantly Higher With a Threshold Value in Central Retinal Vein Occlusion
por: Matsumoto, Makiko, et al.
Publicado: (2020)